Trials / Completed
CompletedNCT00891332
Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer
Phase II Study of S-1 Plus LV (1 Week on and 1 Week Off) as First-line Treatment for Patients With Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Taiho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter study designed to evaluate the response rate of S-1 plus Leucovorin (1 week on and 1 week off) as first -line treatment for patients with metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1 plus LV (The combination therapy of S-1 and Leucovorin) | S-1 40-60 mg bid day 1～day 7 LV 25 mg bid day 1～day 7 |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-11-01
- First posted
- 2009-05-01
- Last updated
- 2012-01-18
Locations
6 sites across 2 countries: China, Japan
Source: ClinicalTrials.gov record NCT00891332. Inclusion in this directory is not an endorsement.